Search

everythinglearnresearchcommunity

for

Search:↓

Thymoma-associated multiorgan autoimmunity can cause liver damage and affects multiple organs, with limited treatment options and a generally poor prognosis.

An 84-year-old man developed a rare scalp condition from a cancer drug but continued treatment as it was otherwise well tolerated.

Idiopathic hypoparathyroidism is rare and can be managed with dihydrotachysterol.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Toxic epidermal necrolysis is a severe skin condition often caused by drugs, with complex treatment and a high risk of death, but survivors usually heal without scars.

Upadacitinib may cause hair loss.

Photodynamic therapy is the preferred treatment for skin precancer due to its effectiveness and safety.

A man's rare tumor caused unusual nerve-related symptoms that improved after surgery.

PROTACs show promise for cancer treatment, but designing them effectively is challenging.

Skin and nail changes are common in patients with blood cancers undergoing chemotherapy, affecting their quality of life.

Finasteride, often used for hair loss, can potentially cause cataracts.

Rare skin cancer can mimic hair loss conditions, so thorough diagnosis is crucial.

Rare ovarian tumors can cause hyperandrogenism, even if imaging appears normal.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

There's an urgent need for better treatments for hair loss caused by radiation therapy.

A woman had a severe skin reaction from the drug imiquimod, used for skin cancer, highlighting the need for awareness of rare but serious side effects.

Preventing and managing skin issues from cancer treatment is crucial, especially in high UV areas like Australia and New Zealand.

Different prostate cancer treatments have similar risks of secondary cancers and related mortality when considering patient age and smoking history.

Some patients developed hair loss after islet cell transplant possibly due to their immune-suppressing medications.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Pegylated interferon-alpha 2a can cause a rare nerve disorder, but early treatment can lead to full recovery.

CI-1033 causes skin lesions in rats, similar to humans, due to EGF receptor inhibition.

Neoadjuvant chemotherapy followed by surgery leads to fewer severe complications and better quality of life than immediate surgery in advanced ovarian cancer patients with high tumor load.

Cyclophosphamide often causes gastrointestinal issues, hair loss, and low blood cell counts in Chinese patients with autoimmune diseases.

The document suggests a possible link between hair loss and thyroid cancer, but doesn't provide definite proof.

A bladder rupture from prostate treatment was healed with catheterization and antibiotics.

Chemotherapy can cause brain inflammation and damage, and understanding this process could help manage side effects.

Targeting amphiregulin may improve treatment for fibrosis and cancer.

Kidney cancer cells without folliculin are more sensitive to radiation due to increased self-eating cell death.

Cyclophosphamide can cause serious short-term and long-term side effects, including increased cancer risk and infertility.